Daybue sales are a key element.
Increase of patients moving onto Daybue,
Return of patients having dropped off Daybue.
And retention rates of those on Daybue.
This gives a good sign post of revenue/profit for NEU. And thus SP calc + milestones coming + “growth factor” for Europe/other territories and NZ2591
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-10799
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.11 |
Change
0.210(1.06%) |
Mkt cap ! $2.543B |
Open | High | Low | Value | Volume |
$20.22 | $20.44 | $20.06 | $812.4K | 40.14K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 202 | $20.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.11 | 51 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 177 | 20.080 |
5 | 356 | 20.070 |
4 | 245 | 20.060 |
3 | 239 | 20.050 |
6 | 783 | 20.040 |
Price($) | Vol. | No. |
---|---|---|
20.110 | 76 | 4 |
20.120 | 273 | 5 |
20.130 | 279 | 4 |
20.140 | 404 | 6 |
20.150 | 354 | 6 |
Last trade - 11.57am 04/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online